NCT02453776View on ClinicalTrials.gov

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Inflammatory Bowel Disease

Interventions

DRUG

PRECISION dosing Infliximab

Patients in the PRECISION dosing arm will recieve model based dosing, whereas proactive adjustments in treatment can be made by measuring the Infliximab concentration.

Trial Locations (1)

1102 AZ

Academic Medical Center, Amsterdam

All Listed Sponsors

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02453776 - Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab | Biotech Hunter | Biotech Hunter